A nurse is caring for a client who is 6 hours postpartum. The client is Rh-negative and her newborn is Rh-positive. The client asks why an indirect Coombs test was ordered by the provider. Which of the following is an appropriate response by the nurse?

Choice a reason:
An irregular fetal heart rate is not typically associated with a hydatidiform mole because, in many cases of complete molar pregnancy, there is no fetus, and thus no fetal heart rate to assess. In partial molar pregnancies, there may be a fetus with an irregular heart rate, but this is not a definitive sign of a hydatidiform mole.

Choice b reason:
Profuse, clear vaginal discharge is not a common finding in hydatidiform mole. The typical vaginal discharge associated with a molar pregnancy is often described as "grape-like" or "prune juice-like" due to the presence of molar tissue being passed.

Choice c reason:
A rapid decline in hCG levels is not expected in hydatidiform mole; in fact, unusually high levels of hCG are more characteristic of this condition. The abnormal placental tissue in a molar pregnancy tends to produce higher than normal amounts of hCG.

Choice d reason:
Excessive uterine enlargement is a key finding in hydatidiform mole. The uterus often becomes larger than expected for the gestational age because the abnormal placental tissue grows rapidly and takes up more space within the uterus. This can happen within 10 to 16 weeks of gestation and is one of the primary clinical signs that lead to the suspicion of a molar pregnancy.

Choice A reason:
Magnesium sulfate is used in the management of severe preeclampsia primarily for seizure prophylaxis. One of the key side effects of magnesium sulfate is its impact on neuromuscular transmission, leading to diminished deep-tendon reflexes as serum magnesium levels rise. The therapeutic range for anticonvulsant prophylaxis is typically between 5-8 mg/dL. Reflexes may begin to diminish when serum levels reach 8-12 mg/dL, indicating potential magnesium toxicity. Therefore, diminished reflexes are a warning sign to reassess the infusion rate and possibly reduce or discontinue the medication.

Choice B reason:
A respiratory rate of 16 breaths per minute falls within the normal adult range and suggests that the client's respiratory system is not being adversely affected by the magnesium sulfate infusion. Respiratory rate is a critical parameter to monitor during magnesium sulfate therapy, as respiratory depression is a serious side effect of magnesium toxicity. Maintaining a normal respiratory rate indicates that it is safe to continue the infusion at the current rate.

Choice C reason:
While a urine output of 50 mL/hr is on the lower end of the normal range, it is still considered adequate for most adults. In the setting of magnesium sulfate therapy for severe preeclampsia, maintaining adequate urine output is essential for ensuring that the kidneys can excrete the magnesium to prevent accumulation and toxicity. If urine output decreases significantly, it may necessitate reevaluation of the infusion rate or additional interventions to support renal function.

Choice D reason:
A heart rate of 56 beats per minute is slightly bradycardic but may not be clinically significant if the client is asymptomatic. However, magnesium has a direct effect on cardiac function, and high levels can lead to bradycardia and other cardiac conduction abnormalities. It is important to monitor the client's heart rate and rhythm during magnesium sulfate therapy to detect any early signs of cardiac involvement due to magnesium toxicity.